XML 64 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Oct. 28, 2022
Oct. 29, 2021
Oct. 28, 2022
Oct. 29, 2021
Disaggregation of Revenue [Line Items]        
Net sales $ 7,585 $ 7,847 $ 14,955 $ 15,835
U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 4,069 3,997 7,835 8,098
Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 2,157 2,478 4,485 5,079
Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 1,359 1,372 2,635 2,658
Cardiovascular        
Disaggregation of Revenue [Line Items]        
Net sales 2,773 2,827 5,486 5,717
Cardiovascular | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 1,424 1,373 2,722 2,793
Cardiovascular | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 802 948 1,694 1,952
Cardiovascular | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 546 506 1,070 972
Medical Surgical        
Disaggregation of Revenue [Line Items]        
Net sales 2,070 2,299 4,071 4,621
Medical Surgical | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 905 970 1,748 1,959
Medical Surgical | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 719 841 1,485 1,710
Medical Surgical | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 446 488 838 951
Neuroscience        
Disaggregation of Revenue [Line Items]        
Net sales 2,186 2,136 4,301 4,340
Neuroscience | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 1,512 1,394 2,931 2,840
Neuroscience | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 382 433 788 898
Neuroscience | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 292 309 582 602
Diabetes        
Disaggregation of Revenue [Line Items]        
Net sales 556 585 1,098 1,157
Diabetes | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 228 261 434 506
Diabetes | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 254 256 518 519
Diabetes | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales $ 74 $ 69 $ 145 $ 132